Seqirus is the global company created from the combined strength and expertise of bioCSL and the influenza vaccines business formerly owned by Novartis.
Now the second largest influenza vaccine company in the world, and with complementary vaccine, anti-venom and diagnostic products, Seqirus has extensive research and production expertise and manufacturing plants in the US, UK and Australia.
With a workforce of over 2,000 employees, significant manufacturing capacity and a commercial presence in 20 countries, Seqirus has ambitious growth targets of a $1bn turnover by 2020.
The future is exciting and full of potential.
Located in Parkville (Australia), a full-time, 12 month maternity leave replacement role within the Global Strategic Labelling team has become available.
As part of this close knit expert team you will :
Tertiary qualified in biological science, allied medical discipline or pharmacy, with complementary experience in a pharmaceutical / biotechnology industry; you ideally possess :
Knowledge of global labelling legislation and guidelines for medicines would be advantageous);.
If you are excited by the possibilities of shaping public health, then please send an application addressing the selection criteria above and including a current CV and covering letter.
Applications will close on Friday 6th July 2018
CSL advises that screening including; criminal history, medical assessment, confirmation of experience, stated qualifications and other relevant checks form a part of the candidate suitability evaluation process.
Where applicable, this applies to current CSL employees. CSL employees must notify their current manager when selected for interview for any advertised internal vacancies.
Important notice to Employment businesses / Agencies
Seqirus does not accept unsolicited referrals from employment businesses and / or employment agencies in respect of the vacancies posted on this site.
All employment businesses / agencies are required to contact Seqirus' Talent Acquisition to obtain prior written authorization before referring any candidates to Seqirus.
The obtaining of prior written authorization is a condition precedent to any agreement (verbal or written) between the employment business / agency and Seqirus.
In the absence of such written authorization being obtained any actions undertaken by the employment business / agency shall be deemed to have been performed without the consent or contractual agreement of Seqirus.
Seqirus shall therefore not be liable for any fees arising from such actions or any fees arising from any referrals by employment businesses / agencies in respect of the vacancies posted on this site.